Date :
Place : United States of America, Boston
Website :https://tcr-therapies-summit.com/
Contact Person:Aoife O'Donnell
Description:
Validate Novel Targets, Uncover Effective Biomarkers and Enhance TCR Discovery and Optimization to Expand Patient Population and Achieve Clinical Validation. Time: 8:00 AM - 4:30 PM. Prices: USD 2599.00 - USD 5097.00.Deadline for abstracts/proposals : 1st April 2025
Organized By :
Keynote Speakers :
Conference Highlights :6th TCR-based Therapies 2025 | April 2-3 2025, Boston
The 6th TCR-Based Therapies Summit returns as the only TCR-specific platform for industry experts to join forces & share technical insights.
April 1-3, 2025 | Boston MA
2024 was pivotal for TCR therapies.Following the commercial approval forAdaptimmune’sTecelra,positive clinical readouts, and FIH trials fromImmatics,Triumvira,Affini-T,CDR-Life,andTScan, along with a wealth of investment and partnerships amounting toover $700M, it’s time to come together torelish in thesebreakthroughs,while pouring this energy into expanding TCR treatment potential.
The6th TCR-Based Therapies Summitreturns as the only TCR-specific platform for industry experts to join forces to share the technical insights to transformdiscovery,translation,R&D,andclinical developmentfor cell- and biologic-based approaches.
Providing an unmatched close-knit collaboration environment created specifically with and for the TCR community to connect, and learn from leaders such asImmunocore,Immatics,Marengo,TScan,Medigene, andBioNTech, in a bid tovalidate novel target antigens, discoversafe,potent and optimized TCRs, boostdurabilityin the solid TME, and delve intoclinical data, to deliver to more patient populations and achieve clinical validation.
Vice President, Global Head of Clinical Sciences
Check the event website for more details.